USDA approves drug for canine allergic and atopic dermatitisJanuary 6, 2026Befrena (tirnovetmab), an antiāIL-31 monoclonal antibody injection for the treatment of canine allergic and atopic dermatitis, is intended for use in dogs of any age and is recommended at dosing intervals of six to eight weeks following treatment.
SPONSORED CONTENTIs your parasite protocol missing something?Adding Hill's GI nutrition to your parasite protocol supports GI healing for more complete diarrhea management than medication alone. + Learn More